Variantyx
Developer of genetic testing platforms designed to improve diagnosis and personalised medicine for rare genetic disorders, reproductive genetics and precision oncology. The company's platform features...
Valuation
$100.5M
Market implied
Share Price
N/A
Total Raised
$177.8M
Last Round
N/A